Oak Ridge Investments’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.68M Buy
27,970
+8,840
+46% +$906K 0.15% 93
2026
Q1
$2.09M Buy
19,130
+2,214
+13% +$211K 0.14% 93
2025
Q4
$1.37M Sell
16,916
-2,543
-13% -$219K 0.08% 112
2025
Q3
$1.7M Sell
19,459
-177
-0.9% -$15.8K 0.11% 102
2025
Q2
$1.63M Sell
19,636
-1,131
-5% -$94.5K 0.12% 99
2025
Q1
$1.74M Sell
20,767
-307
-1% -$28.6K 0.14% 93
2024
Q4
$1.94M Sell
21,074
-677
-3% -$65.1K 0.15% 94
2024
Q3
$2.02M Buy
+21,751
New +$1.88M 0.18% 90

Other funds holding LMAT

Oak Ridge Investments's LMAT Position: Q2 2026 in Review

Oak Ridge Investments increased its LeMaitre Vascular (LMAT) stake by 46% in Q2 2026, buying an estimated $906K and bringing the position to 27,970 shares worth $2.68M. The position accounts for 0.15% of the portfolio, ranked #93.

Oak Ridge Investments first reported a position in LMAT in Q3 2024 and has held it in 8 quarters since. 44 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Oak Ridge Investments held 27,970 shares of LeMaitre Vascular worth $2.68M as of Q2 2026.
  • Oak Ridge Investments bought 8,840 LeMaitre Vascular shares in Q2 2026, an estimated $906K.
  • LeMaitre Vascular made up 0.15% of Oak Ridge Investments's portfolio in Q2 2026, its #93 holding.
  • Oak Ridge Investments first reported a position in LeMaitre Vascular in Q3 2024 and has held it in 8 quarters since.
  • 44 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Oak Ridge Investments's 13F filing for Q2 2026, filed 21 Jul 2026.